WHO approves emergency use of China's Sinopharm Covid-19 vaccine


BEIJING (Global Times): The World Health Organization (WHO) on Friday (May 7) approved the emergency use of the vaccine produced by Chinese firm Sinopharm. Observers said that Chinese vaccines are now "global public goods" in terms of standards, and more developing countries will have access to Chinese vaccines.

"This afternoon, the WHO gave Emergency Use Listing to Sinopharm Beijing's COVID19 vaccine, making it the sixth vaccine to receive WHO validation for safety, efficacy and quality," World Health Organization Director-General Tedros Adhanom Ghebreyesus said on Friday.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

WHO , Sinopharm , covid-19 , vaccine

   

Next In Aseanplus News

High worldwide dengue numbers may not impact Singapore, say experts
Indonesian manufacturing sector remains expansive amid global slowdown, says minister
Thai police seize one tonne of crystal meth worth RM118mil
Car fells off bridge - One dead and five injured in major road crash in Philippines
Vietnam's Hai Phong kicks off Red Flamboyant Festival, marks UNESCO recognition
Motorcycling-Martin wins French GP after intense battle with Bagnaia, Marquez steals second
Two taken to hospital after eight-vehicle chain collision on Singapore's AYE
Death toll in Indonesia floods, landslides now rising to 34; another 16 reported missing
Indonesia’s Prabowo reiterates ‘Asian Way’ to defuse regional tension
PM Srettha: Thailand to tighten border control amid Myanmar conflict

Others Also Read